MarketCap
Facebook
X
Telegram
Acorda Therapeutics Kurshistorie | ACOR
Kurshistorie Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 | 13.5 | 1.85 | 6.74 | 12.2 | 99.8 | 156 | 123 | 221 | 249 | 176 | 173 | 153 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 249 | 1.85 | 108 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
1.83 | - | -6.63 % | $ 13.9 M |  USA |
 |
FSD Pharma
HUGE
|
1.31 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Qilian International Holding Group Limited
QLI
|
2.65 | - | -6.08 % | $ 184 M |  China |
 |
Happiness Biotech Group Limited
HAPP
|
0.22 | - | 1.35 % | $ 17.8 M | China |
 |
Synthetic Biologics
SYN
|
0.96 | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 | - | - | $ 2.02 B | USA |
 |
BioXcel Therapeutics
BTAI
|
1.26 | $ 1.19 | 5.31 % | $ 14.5 M | USA |
 |
Burford Capital Limited
BUR
|
12.7 | $ 4.37 | 0.23 % | $ 958 M |  Britain |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | China |
 |
BeyondSpring
BYSI
|
1.68 | $ 0.84 | 34.27 % | $ 34.5 M | USA |
 |
Corner Growth Acquisition Corp.
COOL
|
11.1 | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Cerus Corporation
CERS
|
2.6 | $ 2.98 | 4.93 % | $ 568 M | USA |
 |
Compugen Ltd.
CGEN
|
2.1 | $ 2.41 | 4.17 % | $ 225 M |  Israel |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M |  Germany |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.31 | - | 0.74 % | $ 768 M | Israel |
 |
Abcam plc
ABCM
|
21.6 | - | - | $ 4.9 B | Britain |
|
Galera Therapeutics
GRTX
|
0.14 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Hepion Pharmaceuticals
HEPA
|
0.04 | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | Germany |
|
Champions Oncology
CSBR
|
6.06 | $ 5.1 | 2.63 % | $ 70.5 M | USA |
 |
Affimed N.V.
AFMD
|
4.41 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
4.37 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
0.47 | - | - | $ 12.5 M |  Belgium |
 |
Adial Pharmaceuticals
ADIL
|
1.96 | $ 3.98 | 1.86 % | $ 2.66 M | USA |
 |
Generation Bio Co.
GBIO
|
2.77 | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
AnaptysBio
ANAB
|
52.8 | $ 58.47 | 4.37 % | $ 1.68 B | USA |
 |
Anika Therapeutics
ANIK
|
14.9 | $ 21.5 | 1.56 % | $ 308 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
4.9 | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
6.04 | - | - | $ 3.37 B | China |
 |
Aurinia Pharmaceuticals
AUPH
|
13.8 | $ 15.47 | 1.91 % | $ 2.08 B | Canada |
 |
GlycoMimetics
GLYC
|
0.28 | - | 9357.83 % | $ 1.01 B | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bicycle Therapeutics plc
BCYC
|
5.07 | $ 3.9 | 0.24 % | $ 270 M | Britain |
 |
Beam Therapeutics
BEAM
|
32.3 | $ 26.75 | 0.91 % | $ 2.65 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
61 | $ 67.36 | 0.99 % | $ 12.9 B | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |